News
D&D Pharmatech raises KRW 20 billion Series A investment - 바이오스펙테이터
www.biospectator.com
국내/외 바이오 기업 이슈 및 정책, 전문가 인터뷰 및 기고 제공
Experimental Drug Stops Parkinson’s Disease Progression in Mice
www.hopkinsmedicine.org
... Soonchunhyang University, Seoul, Republic of Korea; Viktor Roschke of Neuraly Inc.; Shane Liddelow and Ben Barres of Stanford University; ...
Neuraly to Advance Potential Parkinson's Therapy, NLY01, into...
parkinsonsnewstoday.com
Neuraly, a Johns Hopkins University startup, has raised $36 million to move its lead candidate — NLY01 — into clinical testing, possibly this year, as a...
sortiert nach Relevanz / Datum